We are live on ! Find out more
JIC

Johnson Investment Counsel Portfolio holdings

AUM $13.7B
1-Year Est. Return 21.52%
This Fund
S&P 500
This Quarter Est. Return
+12.77%
1 Year Est. Return
+21.52%
3 Year Est. Return
+66.26%
5 Year Est. Return
+83.65%
10 Year Est. Return
+316.44%
AUM
$6B
AUM Growth
+$606M
Cap. Flow
-$21.3M
Cap. Flow %
-0.36%
Top 10 Hldgs %
32.86%
Holding
618
New
45
Increased
213
Reduced
244
Closed
29

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$43.4M
2
HD icon
Home Depot
HD
+$18.7M
3
UL icon
Unilever
UL
+$18M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$11.8M
5
PG icon
Procter & Gamble
PG
+$10.5M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$83.5M
2
TJX icon
TJX Companies
TJX
+$18.9M
3
FHB icon
First Hawaiian
FHB
+$15.2M
4
T icon
AT&T
T
+$12.5M
5
CL icon
Colgate-Palmolive
CL
+$10.5M

Sector Composition

Rank Sector Weight
1 Financials 14.36%
2 Technology 13.39%
3 Healthcare 10.68%
4 Consumer Staples 10.32%
5 Industrials 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KHC icon
401
Kraft Heinz
KHC
$29.2B
$504K 0.01%
14,536
+151
+1% +$4.9K
GL icon
402
Globe Life
GL
$14.1B
$499K 0.01%
5,250
STZ icon
403
Constellation Brands
STZ
$22.9B
$498K 0.01%
2,272
-67
-3% -$13.2K
ALGN icon
404
Align Technology
ALGN
$12.3B
$493K 0.01%
922
-59
-6% -$26.5K
AZO icon
405
AutoZone
AZO
$49.7B
$493K 0.01%
416
EBAY icon
406
eBay
EBAY
$47.2B
$479K 0.01%
9,537
+37
+0.4% +$1.89K
RETA
407
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$478K 0.01%
3,869
EXPD icon
408
Expeditors International
EXPD
$23B
$473K 0.01%
4,973
+7
+0.1% +$638
REGN icon
409
Regeneron Pharmaceuticals
REGN
$82.1B
$470K 0.01%
973
+3
+0.3% +$1.62K
RSP icon
410
Invesco S&P 500 Equal Weight ETF
RSP
$99.4B
$465K 0.01%
3,647
+923
+34% +$110K
VOT icon
411
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.8B
$465K 0.01%
2,193
+111
+5% +$21.9K
PHM icon
412
Pultegroup
PHM
$25.2B
$464K 0.01%
10,736
CTVA icon
413
Corteva
CTVA
$50.9B
$452K 0.01%
11,682
-138
-1% -$4.93K
RPAY icon
414
Repay Holdings
RPAY
$306M
$452K 0.01%
16,600
YUMC icon
415
Yum China
YUMC
$16.3B
$451K 0.01%
7,893
+5
+0.1% +$281
VIVO
416
DELISTED
Meridian Bioscience Inc
VIVO
$451K 0.01%
24,122
-1,975
-8% -$36.9K
BHP icon
417
BHP
BHP
$229B
$449K 0.01%
7,707
+1,906
+33% +$95.5K
OHI icon
418
Omega Healthcare
OHI
$13.8B
$448K 0.01%
12,328
MDYV icon
419
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.87B
$443K 0.01%
7,986
EVRG icon
420
Evergy
EVRG
$18.9B
$442K 0.01%
7,955
HI
421
DELISTED
Hillenbrand
HI
$441K 0.01%
11,089
TFC icon
422
Truist Financial
TFC
$63.9B
$441K 0.01%
9,210
+173
+2% +$7.83K
FUN icon
423
Cedar Fair
FUN
$1.63B
$440K 0.01%
11,189
-500
-4% -$16.6K
MRTX
424
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$439K 0.01%
2,000
DVA icon
425
DaVita
DVA
$11.4B
$436K 0.01%
3,713

Similar funds

Johnson Investment Counsel's Q4 2020 Portfolio in Review

As of Q4 2020, Johnson Investment Counsel held 618 positions worth $6B, up 11% from $5.4B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Johnson Investment Counsel's Q4 2020 filing shows 45 new, 213 increased, 244 reduced and 29 closed positions. Its largest new stake was Kimball International: 102,850 shares worth $1.23M. The largest sale was Accenture, an estimated $83.5M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

  • Johnson Investment Counsel's largest Q4 2020 buy was Kimball International: 102,850 shares worth $1.23M.
  • Johnson Investment Counsel added most to Visa in Q4 2020, an estimated $43.4M increase.
  • Johnson Investment Counsel's biggest Q4 2020 reduction was TJX Companies, cutting an estimated $18.9M.
  • Johnson Investment Counsel fully exited Accenture in Q4 2020, selling an estimated $83.5M.
  • Johnson Investment Counsel's ten largest holdings make up 33% of its $6B portfolio in Q4 2020.
  • Johnson Investment Counsel opened 45 new positions and closed 29 in Q4 2020.
  • Johnson Investment Counsel's portfolio value rose 11% quarter-over-quarter to $6B.

Based on Johnson Investment Counsel's 13F filing for Q4 2020, filed 12 Feb 2021.